Skip To Main Content
Cilia R Pothast on Muck Rack

Cilia R Pothast

As seen in: Wiley Online Library, BioRxiv
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Cilia R

Contact Cilia R, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Increased CD8 T‐cell immunity after COVID‐19 vaccination in lymphoid malignancy patients lacking adequate humoral response: An immune compensation mechanism?

|
By Lara S. Boerenkamp, Cilia R Pothast, Romy C Dijkland, Kayleigh van Dijk
| Wiley Online Library Verified
Supporting Information Filename Description ajh26729-sup-0001-FigureS1.pdfPDF document, 506.9 KB Supplementary Figure 1. Serological response rates two weeks after SARS-CoV-2 mRNA vaccination. ajh26729-sup-0002-FigureS2.pdfPDF document, 477 KB Supplementary Figure 2. Potential predictive factors for serological CD4+ or CD8+ T-cell response. ajh26729-sup-0003-FigureS3.pdfPDF document, 522.9 KB Supplementary Figure 3.
Open in Who Shared Issue with article?

SARS-CoV-2-specific CD4+ and CD8+ T cell responses can originate from cross-reactive CMV-specific T cells

|
By Melissa Thaler, Renate S. Hagedoorn, Cilia R Pothast, Romy C Dijkland
| BioRxiv
Thank you for your interest in spreading the word about bioRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. Message Subject (Your Name) has forwarded a page to you from bioRxiv Message Body (Your Name) thought you would like to see this page from the bioRxiv website.
Open in Who Shared View Duplicates (459) Issue with article?
See all 2 articles